US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 05, 2024

    Publix Wants Ga. High Court Input On Opioid Public Nuisance

    Grocery chain Publix has asked the Ohio federal court overseeing the opioid multidistrict litigation to send questions to Georgia's high court about whether that state's law allows public nuisance claims over a healthcare provider's dispensing of prescription narcotics.

  2. March 19, 2024

    OptumRx Can't Get Motley Rice Disqualified From Opioid MDL

    An Ohio federal judge has denied a bid by pharmacy benefit manager OptumRx to disqualify Motley Rice LLC from representing plaintiffs in the national opioid litigation, saying the company hasn't shown that the firm's prior representation of states investigating opioids puts the company at a disadvantage in the multidistrict litigation.

  3. February 27, 2024

    Hospital Groups Allege Opioid Crisis Damaged Their Finances

    More than 20 hospitals and related companies have joined multidistrict litigation over the opioid epidemic, alleging in a massive new complaint that pharmacies, drug distributors and others contributed to a crisis that damaged hospitals' finances and strained their ability to help patients.

  4. February 26, 2024

    'Rebel Alliance' Seeks Court Rescue In Opioid Discovery Clash

    A discovery dispute that includes references to the Rebel Alliance in the movie "Star Wars" and accusations of circumventing court rules — in a galaxy closer to Ohio — is headed before a federal judge handling multidistrict litigation over the opioid epidemic.

  5. February 01, 2024

    Pharma Hikma Reaches $150M Opioid Settlement With States

    Hikma Pharmaceuticals and several attorneys general announced a $150 million agreement in principle on Thursday resolving cases brought by a group of states and localities alleging the company fueled the opioid crisis by failing to report suspicious opioid orders from potentially illegal distributors.

  6. January 22, 2024

    Motley Rice Fights DQ Bid In Opioid MDL

    Law firms representing governments suing over the opioid epidemic on Monday told an Ohio federal judge that "corporate wrongdoers" don't get to pick who sues them, in response to a pharmacy benefit manager's bid to disqualify Motley Rice LLC over its representation of other governments in prescription drug disputes.

  7. December 15, 2023

    Motley Rice 'Weaponized' Gov. Info For Opioid MDL, PBM Says

    An online pharmacy defending itself amid multidistrict litigation launched by state attorneys general over the opioid epidemic urged a federal judge Friday to disqualify Motley Rice LLC, saying the plaintiffs' firm "weaponized" confidential information it received while investigating on behalf of the government.

  8. October 31, 2023

    6th Circ. Asked To Step Into Opioid Special Master Row

    Pharmacy benefit managers have urged the Sixth Circuit to remove a special master from the opioid multidistrict litigation in Ohio federal court over an accidental reply-all email, saying it showed he had made up his mind even before discovery took place.

  9. October 10, 2023

    Email Flub In Opioid MDL No Basis For Master's Removal

    The Ohio federal judge overseeing the opioid multidistrict litigation on Tuesday refused to remove a special master who misfired a "reply all" email, saying it "unquestionably" contained private deliberations.

  10. September 28, 2023

    Opioid Special Master's Email Doesn't Betray Bias, Court Told

    The plaintiffs' executive committee in multidistrict opioid litigation against pharmacy benefit managers OptumRX Inc. and Express Scripts Inc. has urged an Ohio federal court to reject their bid to disqualify the special master who sent a misfired "reply all" email.